Monthly versus quarterly dutasteride mesotherapy for male androgenetic alopecia: A randomized trial.
Baltazar Sanabria,
Marcelo Zanolli Medeiros,
Hélio Amante Miot,
Paulo Müller Ramos
Other
Journal of the European Academy of Dermatology and Venereology : JEADV
2025
PubMed
DOI
<\/script>\n`;
},
get iframeSnippet() {
const domain = 'haircited.com';
const params = 'pmid\u003D41328478';
return ``;
},
get activeSnippet() {
return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet;
},
copySnippet() {
navigator.clipboard.writeText(this.activeSnippet).then(() => {
this.copied = true;
setTimeout(() => { this.copied = false; }, 2000);
});
}
}"
@keydown.escape.window="open = false"
@click.outside="open = false">
Used In Evidence Reviews
Similar Papers
Expert opinion on pharmacotherapy · 2010
Male androgenetic alopecia.
264 citations
Open Access
Journal of the European Academy of Dermatology and Venereology : JEADV · 2018
Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men - short version.
248 citations
Open Access
Journal of the American Academy of Dermatology · 2014
A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia.
160 citations
Skin therapy letter · 2012
Promising therapies for treating and/or preventing androgenic alopecia.
100 citations
Journal of the American Academy of Dermatology · 2019
Androgens in women: Androgen-mediated skin disease and patient evaluation.
95 citations
Fertility and sterility · 2020
Post-finasteride syndrome: a surmountable challenge for clinicians.
94 citations
Open Access